Further evaluation of the antitumor activity of homofolate and its reduced derivatives against methotrexate-insensitive tumors.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001205:Ascorbic Acid; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002460:Cell Line / Q000187:drug effects; D005493:Folic Acid Antagonists; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D001205:Ascorbic Acid; D008727:Methotrexate